Viloxazine Hydrochloride

CAS 3564-70-7 16 API suppliersSmall Molecule

Overview

Viloxazine Hydrochloride is a selective norepinephrine reuptake inhibitor used primarily in the treatment of attention deficit hyperactivity disorder (ADHD). It works by modulating the levels of certain neurotransmitters in the brain to improve attention, focus, and impulsivity.

API suppliers (16)

Suppliers of Viloxazine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India12Italy1Spain1Canada1United States1

12 of 16 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

Attention Deficit Hyperactivity Disorder (ADHD)Norepinephrine Reuptake Inhibitor
Verified Supplier Partner

Do you supply Viloxazine Hydrochloride? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.